RxDoctor Payments Data

Rengarajan Janakiraman, MD

Anesthesiology · Torrington, CTNPI 1407173479

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,924 of the $3,109 with a category attached, or 61.9%. 10 manufacturers reported payments, led by Bioventus LLC at 40.5% of the total. 2025 is the largest year on record at $2,102, more than ten times the $103 reported in 2019. Among anesthesiology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,109in general payments, 2019–2025

Across 41 payments — averaging $75.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bioventus LLC$1K
  • Pacira Pharmaceuticals Incorporated$1K
  • AbbVie$215
  • SPR Therapeutics, Inc$194
  • Merck$181
  • Vertos Medical, Inc.$117
  • plus $97 from 4 others

What the payments were for

  • Travel & lodging$1,92462%
  • Food & beverage$1,18538%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,109 in reported general payments places this provider in the 95th percentile of 664 anesthesiology providers in Connecticut.

See all anesthesiology providers in Connecticut

Medicare billing

Part B allowed, 2024
$26,817
Medicare patients
126
Services billed
280

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine47$5,588
Celecoxib52$2,177
Gabapentin59$545
Methocarbamol25$287
Ibuprofen14$249
Baclofen30$241
Hydromorphone Hcl15$195
Meloxicam40$141
Cyclobenzaprine Hcl32$77

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Torrington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →